Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Travere Therapeutics
Pharma
Despite trial scare, Travere's IgAN drug wins full FDA approval
The full approval puts Travere in a better position in its competition with Novartis in the kidney disease IgAN.
Angus Liu
Sep 5, 2024 5:40pm
Novartis’ Fabhalta wins expanded FDA nod in IgAN
Aug 8, 2024 3:18am
Novartis rides IgAN trioka to trial wins in rare kidney diseases
May 28, 2024 11:20am
EU regulator says yes to Tavere's Filspari, several other meds
Feb 23, 2024 12:12pm
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
Dec 20, 2023 5:24pm
Travere cuts 20% of workforce, aims to win full nod for Filspari
Dec 5, 2023 11:26am
